Davern T J, Scharschmidt B F
Department of Medicine, University of California, San Francisco 94143-0538, USA.
Dig Dis. 1998 Jan-Feb;16(1):23-37. doi: 10.1159/000016846.
With major advances in biomedical science over the last 2 decades, the possibility of treating human disease at a genetic level has become a tantalizing possibility. As a result, a growing number of investigators are focusing on the development of techniques to deliver therapeutic genes into cells. The liver has been a model organ in the development of this gene transfer technology. This review focuses on the attributes and limitations of the current gene delivery systems that have been explored in the context of liver disease and highlights the obstacles that must be addressed before hepatic gene therapy becomes a clinical reality.
在过去20年里,随着生物医学科学取得重大进展,在基因水平上治疗人类疾病的可能性已成为一种诱人的前景。因此,越来越多的研究人员专注于开发将治疗性基因导入细胞的技术。肝脏一直是这种基因转移技术发展中的一个模型器官。这篇综述重点介绍了在肝病背景下已探索的当前基因递送系统的特性和局限性,并强调了在肝脏基因治疗成为临床现实之前必须解决的障碍。